Clinical experience of non-invasive prenatal chromosomal aneuploidy testing in 190,277 patient samples

Current Molecular Medicine

Volumn 16, Issue 8, 2016, Pages 759-766

  Hu, H ^a   Liu, H ^b   Peng, C ^b   Deng, T ^c   Fu, X ^d,e   Chung, C ^e   Zhang, E ^e   Lu, C ^e,f   Zhang, K ^e   Liang, Z ^a   Yang, Y ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CapitalBio Genomics Co   (China)

^c CapitalBio MedLab ^*  (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f Guangzhou KangRui Biological Pharmaceutical Technology Company Ltd   (China)

Author keywords

Clinical experience; Copy number variation (CNVs); False negative; Mosaicism; Noninvasive prenatal testing (NIPT); Trisomy

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; COPY NUMBER VARIATION; DNA LIBRARY; FEMALE; GENE SEQUENCE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; KARYOTYPING; MATERNAL SERUM SCREENING TEST; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRENATAL SCREENING; SEMICONDUCTOR SEQUENCING; SENSITIVITY AND SPECIFICITY; SEX CHROMOSOME; SPONTANEOUS ABORTION; TRISOMY 13; TRISOMY 18; TRISOMY 21; ADOLESCENT; CLINICAL TRIAL; DOWN SYNDROME; HEALTH SURVEY; MIDDLE AGED; MOSAICISM; MULTICENTER STUDY; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY; TRISOMY; YOUNG ADULT;

ADOLESCENT; ADULT; ANEUPLOIDY; DNA COPY NUMBER VARIATIONS; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; MIDDLE AGED; MOSAICISM; POPULATION SURVEILLANCE; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRISOMY; YOUNG ADULT;

EID: 84995961254     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524016666161013142335     Document Type: Article

References (37)

1. Sachs A, Blanchard L, Buchanan A, Norwitz E, Bianchi DW. Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective. Prenat Diagn 2015; 35: 968-71
2. Zhang H, Gao Y, Jiang F, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol 2015; 45: 530-8
3. McCullough RM, Almasri EA, Guan X, et al. Non-invasive prenatal chromosomal aneuploidy testing--clinical experience: 100,000 clinical samples. PLoS One 2014; 9: e109173
4. Langlois S, Brock JA, Wilson RD, et al. Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. J Obstet Gynaecol Can 2013; 35: 177-83
5. Devers PL, Cronister A, Ormond KE, Facio F, Brasington CK, Flodman P. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns 2013; 22: 291-5
6. Bajpai M, Aviv H, Das KM. Prolonged exposure to acid and bile induces chromosome abnormalities that precede malignant transformation of benign Barrett’s epithelium. Mol Cytogenet 2012; 5: 43
7. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013; 15: 395-8
8. Benn P, Cuckle H, Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 2013; 42: 15-33
9. Benn P. Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects. J Clin Med 2014; 3: 537-65
10. Yin AH, Peng CF, Zhao X, et al. Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA. Proc Natl Acad Sci U S A 2015; 112: 14670-5
11. Liao C, Yin AH, Peng CF, et al. Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing, Proc Natl Acad Sci U S A 2014; 111: 7415-20
12. Malone FD, Eddleman KA. Procedure-related complications of amniocentesis and chorionic villus sampling. Obstet Gynecol 2007; 110: 1425-6; author reply 1426
13. Kollmann M, Haeusler M, Haas J, Csapo B, Lang U, Klaritsch P. Procedure-related complications after genetic amniocentesis and chorionic villus sampling. Ultraschall Med 2013; 34: 345-8
14. Shahbazian N, Barati M, Arian P, Saadati N. Comparison of complications of chorionic villus sampling and amniocentesis. Int J Fertil Steril 2012; 5: 241-4
15. Suzumori N, Ebara T, Yamada T, et al. Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy. J Hum Genet 2016; 61: 647-52
16. Samuel AR, Son M, Ananth CV, Wapner RJ. The effect of chorionic villus sampling on the fraction of cell-free fetal DNA in maternal plasma. J Matern Fetal Neonatal Med 2016; 29: 2654-7
17. Zhou Y, Zhu Z, Gao Y, et al. Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma. Reprod Sci 2015; 22: 1429-35
18. Bakker M, Birnie E, Robles de Medina P, Sollie K, Pajkrt E, Bilardo CM. Total pregnancy loss after chorionic villus sampling and amniocentesis - A cohort study. Ultrasound Obstet Gynecol 2016; doi: 10.1002/uog.15986. [Epub ahead of print]
19. Tabor A, Vestergaard CH, Lidegaard O. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol 2009; 34: 19-24
20. Benn P. Expanding non-invasive prenatal testing beyond chromosomes 21, 18, 13, X and Y. Clin Genet 2016; doi: 10.1111/cge.12818. [Epub ahead of print]
21. Gekas J, Langlois S, Ravitsky V, et al. Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues. Appl Clin Genet 2016; 9: 15-26
22. Dondorp W, de Wert G, Bombard Y, et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet 2015; 23: 1438-50
23. Kalafat E, Seval MM, Turgay B, Koc A. Non-invasive prenatal testing for sex chromosome abnormalities: a source of confusion. BMJ Case Rep 2015; 2015. pii: bcr2014207309
24. Taylor-Phillips S, Freeman K, Geppert J, et al. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open 2016; 6: e010002
25. Lin G, Zhang K, Li J. Application of CRISPR/Cas9 Technology to HBV. Int J Mol Sci 2015; 16: 26077-86
26. Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn 2013; 33: 667-74
27. Yao H, Zhang L, Zhang H, et al. Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X. Prenat Diagn 2012; 32: 1114-6
28. Choi H, Lau TK, Jiang FM, et al. Fetal aneuploidy screening by maternal plasma DNA sequencing: ‘false positive’ due to confined placental mosaicism. Prenat Diagn 2013; 33: 198-200
29. Chu T, Yeniterzi S, Yatsenko SA, et al. Cell-free nucleic acids as non-invasive biomarkers of gynecological disorders, fetal aneuploidy and constitutional maternal chromosomal mosaicism. Hum Reprod Update 2015; 21: 690-2
30. Vlkova B, Hodosy J. Vanishing twin as a potential source of bias in non-invasive fetal sex determination: a case report. J Obstet Gynaecol Res 2014; 40: 1128-31
31. Samango-Sprouse C, Banjevic M, Ryan A, et al. SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy. Prenat Diagn 2013; 33: 643-9
32. Tsui NB, Wong BC, Leung TY, Lau TK, Chiu RW, Lo YM. Non-invasive prenatal detection of fetal trisomy 18 by RNA-SNP allelic ratio analysis using maternal plasma SERPINB2 mRNA: a feasibility study. Prenat Diagn 2009; 29: 1031-7
33. Xu XP, Gan HY, Li FX, et al. A Method to Quantify Cell-Free Fetal DNA Fraction in Maternal Plasma Using Next Generation Sequencing: Its Application in Non-Invasive Prenatal Chromosomal Aneuploidy Detection. PLoS One 2016; 11: e0146997
34. Lau TK, Jiang F, Chan MK, Zhang H, Lo PS, Wang W. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies. J Matern Fetal Neonatal Med 2013; 26: 434-7
35. Tan Y, Gao Y, Lin G, et al. Noninvasive prenatal testing (NIPT) in twin pregnancies with treatment of assisted reproductive techniques (ART) in a single center. Prenat Diagn 2016; 36: 672-9
36. Fosler L, Winters P, Jones KW, et al. Aneuploidy Screening Using Noninvasive Prenatal Testing in Twin Pregnancies. Ultrasound Obstet Gynecol 2016; doi: 10.1002/uog.15964. [Epub ahead of print]
37. Huang X, Zheng J, Chen M, et al. Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies. Prenat Diagn 2014; 34: 335-40